Novel psychoactive substances

Autor: Iain F Brew

Publikováno v: The British journal of general practice : the journal of the Royal College of General Practitioners. 66(644)

Gilani does well to highlight the increasing and concerning use of novel psychoactive substances (NPS) in the UK.1 We have seen the damaging and unpredictable effects of synthetic cannabinoids in prisons …

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fa95f26330657fa97f2877afebc9d047
https://pubmed.ncbi.nlm.nih.gov/26719457

Is increased hepatitis C virus case-finding combined with current or 8-week to 12-week direct-acting antiviral therapy cost-effective in UK prisons? A prevention benefit analysis

Autor: Sharon J. Hutchinson, Éamonn O'Moore, Alec Miners, Matthew Hickman, Sushma Saksena, Iain F. Brew, Natasha K. Martin, Sema Mandal, William L. Irving, Joan Williamson, Peter Vickerman

Publikováno v: Hepatology (Baltimore, Md.), vol 63, iss 6
Martin, N K, Vickerman, P, Brew, I F, Williamson, J, Miners, A, Irving, W L, Saksena, S, Hutchinson, S J, Mandal, S, O'Moore, E & Hickman, M 2016, ' Is increased hepatitis C virus case-finding combined with current or 8-week to 12-week direct-acting antiviral therapy cost-effective in UK prisons? A prevention benefit analysis ', Hepatology, vol. 63, no. 6, pp. 1796-1808 . https://doi.org/10.1002/hep.28497

Prisoners have a high prevalence of hepatitis C virus (HCV), but case-finding may not have been cost-effective because treatment often exceeded average prison stay combined with a lack of continuity of care. We assessed the cost-effectiveness of incr

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a80574f43690d73839db3de1f14dc19
https://pubmed.ncbi.nlm.nih.gov/27118063